glp-1 obesity drug news today september 15 2025 Swiss Re says drugs could reduce US mortality by up to 6.4% Trump announces $50/month GLP-1 weight
Description
These effects are mediated through GLP-1 receptors (GLP-1R), which are widely distributed throughout the body, including the pancreas, liver, skeletal muscle, gastrointestinal tract, cardiovascular system, and central nervous system
Besch G, Perrotti A, Mauny F, et al
[DOI] [PubMed] [Google Scholar] 42.Prausnitz MR, Langer R
10.1210/edrv.18.6.0318 Endocr Rev
We previously found that fusion of a peptide or a single-chain variable fragment to the C-terminal end of albumin reduced FcRn binding up to 2-fold, and to a greater extent than when fused to the N-terminal end 12
The most common drug-related adverse events were nausea, constipation and vomiting
